Your browser is no longer supported. Please, upgrade your browser.
We’ve released a new Beta version of our Futures section! Try it now. We look forward to your feedback! ×
PRGO [NYSE]
Perrigo Company Public Limited Company
IndexS&P 500 P/E77.42 EPS (ttm)2.57 Insider Own0.10% Shs Outstand140.78M Perf Week0.22%
Market Cap28.01B Forward P/E23.20 EPS next Y8.58 Insider Trans-13.57% Shs Float140.08M Perf Month14.55%
Income346.50M PEG6.26 EPS next Q1.76 Inst Own77.90% Short Float1.58% Perf Quarter25.63%
Sales4.17B P/S6.72 EPS this Y-62.00% Inst Trans-0.90% Short Ratio1.47 Perf Half Y36.63%
Book/sh71.28 P/B2.79 EPS next Y17.22% ROA2.40% Target Price183.17 Perf Year39.25%
Cash/sh25.69 P/C7.75 EPS next 5Y12.38% ROE3.90% 52W Range125.00 - 215.73 Perf YTD19.13%
Dividend0.50 P/FCF37.75 EPS past 5Y3.10% ROI2.80% 52W High-7.76% Beta0.28
Dividend %0.25% Quick Ratio3.60 Sales past 5Y15.20% Gross Margin34.40% 52W Low59.19% ATR6.60
Employees10220 Current Ratio4.00 Sales Q/Q-44.00% Oper. Margin15.70% RSI (14)74.46 Volatility2.86% 3.78%
OptionableYes Debt/Eq0.49 EPS Q/Q96.20% Profit Margin8.30% Rel Volume3.88 Prev Close199.00
ShortableYes LT Debt/Eq0.46 EarningsMay 06 BMO Payout16.20% Avg Volume1.51M Price198.98
Recom2.00 SMA2011.78% SMA5020.51% SMA20027.13% Volume5,847,271 Change-0.01%
Apr-10-15Downgrade Argus Buy → Hold
Feb-06-15Reiterated RBC Capital Mkts Outperform $177 → $175
Nov-12-14Reiterated Argus Buy $160 → $175
Nov-07-14Reiterated RBC Capital Mkts Outperform $169 → $177
Sep-22-14Reiterated RBC Capital Mkts Outperform $160 → $169
May-15-14Reiterated Argus Buy $175 → $160
May-08-14Reiterated B. Riley & Co. Neutral $170 → $157
May-08-14Downgrade RBC Capital Mkts Top Pick → Outperform $187 → $160
Mar-03-14Reiterated UBS Buy $176 → $190
Mar-03-14Reiterated Stifel Buy $165 → $175
Feb-25-14Reiterated CRT Capital Buy $165 → $175
Feb-07-14Downgrade B. Riley & Co. Buy → Neutral
Jan-16-14Reiterated Argus Buy $160 → $175
Jan-07-14Initiated RBC Capital Mkts Top Pick $187
Dec-12-13Reiterated Stifel Buy $150 → $165
Nov-07-13Reiterated Argus Buy $152 → $160
Nov-04-13Reiterated UBS Buy $140 → $160
Oct-21-13Initiated Argus Buy $152
Sep-17-13Initiated CRT Capital Buy $145
Jul-30-13Reiterated B. Riley & Co. Buy $139 → $145
Apr-17-15 04:28PM  It was a day to forget on Wall Street...
03:31PM  Mylan says merger with Teva would be bad fit
03:17PM  Mylan: There's No Logic In The Teva Merger Rumor
02:58PM  Mylan to Teva: Thanks but no thanks, we'll stay independent at bizjournals.com
02:50PM  Mylan: Fully committed to stand alone strategy
02:37PM  Teva considering potential bid for Mylan - Bloomberg
02:31PM  Teva considering bid for Mylan: Report at CNBC
02:25PM  Teva considering bid for Mylan: DJ
Apr-16-15 02:24PM  Perrigo Announces The Launch Of A Generic Version Of Kenalog® Nasal Spray at noodls
02:10PM  Perrigo Announces The Launch Of A Generic Version Of Kenalog® Nasal Spray PR Newswire
08:45AM  Global Pharma Company Mylan Offers to Buy Perrigo
Apr-15-15 03:52PM  Bucking The Trend With Pattern Failure Strategies at Investopedia
Apr-13-15 11:05PM  Magnetar Capital Raises Its Stake in Actavis
07:16PM  Cramer Remix: This is what I think of Netflix at CNBC
03:25PM  Mylan Notifies Perrigo of HSR Filing Regarding Proposed Acquisition at noodls
02:11PM  Pharma ETFs Soar on Acquisition Spree - ETF News And Commentary
01:43PM  Why The Mylan 'Love Triangle' Could Benefit Investors
06:45AM  Mylan Notifies Perrigo of HSR Filing Regarding Proposed Acquisition PR Newswire
Apr-12-15 09:50PM  The presidency, #ImNoAngel and a $29B acquisition are on the minds of our women to watch this week at bizjournals.com
08:52PM  MoneyBeat: Big Deals Are a Big Deal at The Wall Street Journal
Apr-09-15 06:25PM  Specialty pharma; remember those two words: Cramer
06:00PM  Cramer: Invest in best of breed
05:10PM  Gap shares decline as sales fall at namesake store at MarketWatch
02:40PM  Should Mylan Marry Perrigo Or Teva? Street Debates at Investor's Business Daily
02:26PM  Top trades to go before Thursday's close at CNBC
12:02PM  Altera tumbles as Intel walks away; Zynga changes trigger selling
11:32AM  1 Challenge Bank Of America Sees For Mylan And Perrigo
10:50AM  Mylan Proposes to Acquire Perrigo, Sets Both Stocks Soaring - Analyst Blog
10:40AM  Everything is up for grabs in pharmaceuticals: Pro
10:37AM  The Winner In A Mylan-Perrigo Deal? Teva, Says Citi at Barrons.com
09:44AM  Faber Report: Mylan to buy Perrigo
08:52AM  Cramer's stocks to watch: Perrigo & Mylan
08:07AM  U.S. stocks: Futures waver as investors digest Fed minutes, earnings at MarketWatch
07:00AM  Jim Cramer -- Mylan's Move to Acquire Perrigo a Prescription for Success at TheStreet
Apr-08-15 08:21PM  Jim Cramer's 'Mad Money' Recap: Really, Cheaper Oil Is Good for Stocks at TheStreet +18.39%
08:17PM  PRESS DIGEST- Financial Times - April 9 Reuters
07:14PM  Cramer Remix: Playing the Apple downgrade at CNBC
06:36PM  Cramer: Instant wealth? The right way to do a deal at CNBC
06:25PM  The 'Goofus and Gallant' of the M&A world: Cramer
06:12PM  Mylan Offers $29 Billion For Perrigo, Sending Both Stocks Soaring To Highs
05:44PM  Watching the Fed through jobless claims at CNBC
05:25PM  Mylan Bids $29 Billion for Perrigo in Latest Big Pharma Deal at TheStreet
05:07PM  Stocks Rise After March FOMC Minutes at Barrons.com
04:59PM  Generic drugmaker Mylan offers $29 bln for Perrigo Reuters
04:46PM  U.S. stocks finish slightly higher after release of Fed minutes at MarketWatch
04:14PM  Stocks Eke Out Gains After Divided Fed Fuels Choppiness at TheStreet
04:00PM  Is Teva A Better Target For Mylan Than Perrigo? 2 Analysts Share Their Thoughts
03:50PM  Perrigo options attracted large bullish bet ahead of Mylan offer Reuters
01:08PM  Announcement Regarding Possible Offer at noodls
01:01PM  Mylan's nearly $30 billion proposal
01:00PM  Announcement Regarding Possible Offer PR Newswire
12:48PM  Pharma ETFs Boosted by Mylans Giant Offer for Perrigo
12:28PM  Mylan goes big with $29 billion offer to buy Perrigo at Fortune
12:25PM  Can Perrigo Get More From Mylan? at 24/7 Wall St.
12:18PM  Mylan's bid for Perrigo leading to a $700 million payday for Abbott Labs at MarketWatch
12:15PM  Mylan makes $29B bid for Perrigo at bizjournals.com
11:56AM  Mylan Proposes To Acquire Perrigo For $205 Per Share at noodls
11:54AM  Mylan makes bid for Perrigo
11:46AM  Mylan proposes to buy Perrigo for about $29 bln
11:39AM  Mylan Bids for Perrigo at The Wall Street Journal
11:29AM  Mylan Proposes To Acquire Perrigo For $205 Per Share PR Newswire
09:21AM  Perrigo Announces FDA Approval and Upcoming Launch of the AB Therapeutic Equivalent to Exalgo® at noodls
08:53AM  Perrigo Announces FDA Approval and Upcoming Launch of the AB Therapeutic Equivalent to Exalgo® PR Newswire
Apr-06-15 01:05PM  Multiple Opportunities in the International Generics Market
Mar-30-15 11:21AM  Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company at noodls
10:46AM  Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company PR Newswire
09:54AM  Cramer's Stop Trading: Perrigo
08:51AM  Cramer's stocks to watch: Perrigo, Teva & GNC
Mar-25-15 12:07PM  Bargaining Power Is in the Hands of the Distribution Industry
07:26AM  Perrigo trade has bullish prescription
Mar-23-15 01:05PM  Generics Are Climbing up the Value Chain
Mar-11-15 10:10AM  Q&A: Jerome Dodson, Parnassus Endeavor at USA TODAY
Mar-04-15 09:26AM  SENTRY® Fiproguard® Plus Flea and Tick Topical, SENTRY® Soft & Chewy Supplements Unveiled at Global Pet Expo at noodls
08:58AM  PetArmor® Plus Flea and Tick Topical, PetArmor® Soft & Chewy Supplements Unveiled at Global Pet Expo at noodls
08:57AM  SENTRY® Fiproguard® Plus Flea and Tick Topical, SENTRY® Soft & Chewy Supplements Unveiled at Global Pet Expo PR Newswire
08:54AM  PetArmor® Plus Flea and Tick Topical, PetArmor® Soft & Chewy Supplements Unveiled at Global Pet Expo PR Newswire
08:31AM  Perrigo Company To Present At The 2015 Barclays Global Healthcare Conference at noodls
08:09AM  Perrigo Company To Present At The 2015 Barclays Global Healthcare Conference PR Newswire
06:00AM  Jim Cramer's Top Stock Picks: DIN PRGO at TheStreet
Mar-03-15 07:11PM  Cramer Remix: This makes $ on Lumber Liquidators at CNBC
06:31PM  Cramer blows the whistle on China at CNBC
06:25PM  Cramer: Dangerous theme behind some stocks CNBC
06:00PM  Cramer: The stock capitalizing on Lumber Liquidators CNBC
12:18PM  Perrigo (PRGO) Stock Lower Today After Deutsche Bank Price Target Reduction at TheStreet
05:35AM  Cramer: Are Chinese Vitamins Next? TheStreet
Feb-26-15 09:30AM  Israel ETFs in Focus on Surprise Rate Cut - ETF News And Commentary Zacks
Feb-20-15 06:00PM  CEOs to Cramer: This is how we win CNBC
06:00AM  Jim Cramer's Top Stock Picks: TMUS SBUX EOG JACK PRGO WMT at TheStreet
Feb-19-15 07:56PM  Jim Cramer's 'Mad Money' Recap: 8 CEOs I Want on My All-Star Team at TheStreet
07:03PM  Cramer Remix: Avoid this at all costs at CNBC
Feb-17-15 08:01AM  Perrigo Company To Present At The 2015 RBC Global Healthcare Conference PR Newswire
Feb-10-15 09:31AM  Moody's: Large healthcare acquirers will show different rates of deleveraging in 2015 at Moody's
Feb-06-15 11:11AM  Three Reasons To Let Akorn Fall Into Your Portfolio at Investor's Business Daily
09:08AM  Perrigo Co (PRGO) Earnings Report: Q2 2015 Conference Call Transcript at TheStreet
07:00AM  Perrigo Company plc (PRGO): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report Zacks
Feb-05-15 05:33PM  Generic-Drug Makers Soar, And It's Easy To See Why at Investor's Business Daily
05:03PM  Stocks Rise In Weak Trade; LinkedIn Jumps After Hours at Investor's Business Daily
04:18PM  Stocks Close Near Session Highs, But Volume Softens at Investor's Business Daily
10:15AM  Perrigo Beats on Earnings, FY15 Guidance In Line - Analyst Blog Zacks
08:46AM  Perrigo (PRGO) Beats on Q4 Earnings, Revenues In Line - Tale of the Tape Zacks
Perrigo Company plc, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API). Its Consumer Healthcare segment offers OTC pharmaceutical products in the areas of analgesics, cough/cold/allergy/sinus, gastrointestinal, smoking cessation, and animal health products, as well as in the areas of feminine hygiene, diabetes care, and dermatological care; and contract manufacturing services. The company's Nutritionals segment offers infant and toddler formula products, infant and toddler foods, as well as vitamins, minerals, and dietary supplement products to retailers, distributors, and consumers. Its Rx Pharmaceuticals segment develops, manufactures and markets a portfolio of Rx drugs in topical dosage forms, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, and powders, as well as controlled substances, injectables, hormones, oral solid dosage forms, and oral liquid formulations. This segment provides its products to chain drug stores, wholesalers, distributors, hospital systems, and group purchasing organizations. The company's API segment develops, manufactures, and markets API that are used in the production of pharmaceutical products to generic drug industries and branded pharmaceutical companies. Its Specialty Sciences segment provides Tysabri, which is used for the treatment of Multiple Sclerosis; and Prialt, a non-narcotic intrathecal analgesic. The company also offers pharmaceutical and medical diagnostic products. The company offers its products primarily in the United States, the United Kingdom, Mexico, Israel, and Australia, as well as in Canada, China, and Latin America. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HENDRICKSON JOHN TEVP Global Operations & SupplyApr 14Option Exercise107.058,800941,9974,148Apr 16 04:14 PM
HENDRICKSON JOHN TEVP Global Operations & SupplyApr 14Sale200.278,8001,762,3760Apr 16 04:14 PM
KINGMA TODD WExecutive VP, General CounselApr 13Option Exercise35.851,30046,60510,664Apr 15 02:57 PM
KINGMA TODD WExecutive VP, General CounselApr 13Sale198.441,300257,9729,364Apr 15 02:57 PM
Shah JatinSr VP & Chief Scientific OfficMar 13Sale165.502,000331,0003,291Mar 17 10:50 AM
Yu LouisExecutive VP Global QualityMar 12Sale166.2714023,2784,746Mar 16 04:35 PM
Farrington ThomasSenior VP and CIOFeb 20Sale151.1851778,161321Feb 24 04:26 PM
Farrington ThomasSenior VP and CIOFeb 06Option Exercise0.0079801,119Feb 09 04:37 PM
MORRIS HERMAN JRDirectorNov 14Sale154.4220030,8831,400Nov 17 05:22 PM
Kochan SharonEVP, GM InternationalNov 10Option Exercise90.655,367486,51910,767Nov 12 04:37 PM
Kochan SharonEVP, GM InternationalNov 10Sale156.365,367839,1845,400Nov 12 04:37 PM
Yu LouisExecutive VP Global QualityNov 10Sale155.1125940,1734,886Nov 12 04:33 PM
Brown Judy LExecutive VP & CFONov 03Option Exercise48.923,515171,9539,445Nov 05 04:39 PM
Brown Judy LExecutive VP & CFONov 03Sale160.603,515564,5077,445Nov 05 04:39 PM
Brown Judy LExecutive VP & CFOOct 01Option Exercise48.923,515171,9539,445Oct 02 04:26 PM
Brown Judy LExecutive VP & CFOOct 01Sale150.723,515529,7817,445Oct 02 04:26 PM
Kochan SharonEVP, GM InternationalSep 03Sale150.001,116167,4005,400Sep 04 04:42 PM
KINGMA TODD WExecutive VP, General CounselSep 03Sale150.101,000150,0952,000Sep 03 05:00 PM
Farrington ThomasSenior VP and CIOSep 02Sale150.361,741261,773321Sep 03 05:12 PM
KINGMA TODD WExecutive VP, General CounselAug 29Option Exercise35.851,25044,81310,614Sep 03 05:00 PM
KINGMA TODD WExecutive VP, General CounselAug 29Sale149.301,250186,6259,364Sep 03 05:00 PM